Cardiac Rehabilitation Market Size & Share, by Indication (Coronary Artery Disease (CAD), Heart Failure, Post-Surgical Rehabilitation); Product; End user- Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037.

Cardiac Rehabilitation Market Regional Analysis

North America Market Insights

North America is poised to dominate the global cardiac rehabilitation market by capturing the largest share of 40.3% by the end of 2037. This proprietorship is primarily attributable to the enlarging patient pool and increasing burden of obesity. Testifying the same, the Centers for Disease Control and Prevention (CDC) reported that, till 2024, yearly more than 8.6 million people with CVD across the region required CR-related commodities. In response, the reimbursement structure in developed nations, such as the U.S. and Canada, expanded the coverage to meet the growing demand for rehabilitation solutions, driving a notable surge in this sector. Furthermore, the well-established clinical pathways for post-cardiac event care, present in North America, are solidifying its position.

According to the CMS, the U.S. Medicare coverage for eligible cardiac patients reached 72.3%. In addition, the emergence of hybrid clinic-home rehab models captivated 35.4% of the nationwide government-backed programs with enhanced post-surgical and cardiological event care. This signifies the country's commitment to greater accessibility of advanced heart-related medical solutions, driving adoption in the domestic market. However, the need for Medicaid expansion in the U.S. is still persistent and is imposing disparities among low-income residents, due to having just 28.3% coverage.

The growth in the Canada cardiac rehabilitation market is majorly fueled by provincial investments from Federal and institutional authorities. For instance, in 2024, the government of Ontario allocated CAD 180.4 million for tele-rehab solutions. Besides, in the same year, Health Canada implemented its CVD strategy, with an aim to make the count of CR users around the country 1.2 million by the end of 2030. Such initiatives evidently propelled adoption in this field, where 45.2% of CR users were accessing home-based programs in 2023 alone, as per the Canadian Institute for Health Information (CIHI).

APAC Market Insights

Asia Pacific is predicted to exhibit the highest CAGR of 8.4% in the global cardiac rehabilitation market over the analyzed tenure. The magnifying burden of CVD occurrence, mortality, and hospitalization is the major accelerating factor of the region's propagation. In this regard, the WHO revealed that more than 12.4 million people across APAC die every year due to this ailment. On the other hand, from 2015 to 2025, the CR patient pool in Korea increased by 50.1%. Additionally, rapid aging, urbanization, infrastructural development, and healthcare modernization accumulatively stimulate innovation and deployment in this category at a larger scale.

China is maintaining regional dominance in the cardiac rehabilitation market with strong government support, a large patient population, and continuous expansion in the medical device industry. Particularly, in tier-2 cities, the demand for CR accounts for 40.2% of the nationwide need, as per a report from the National Health and Family Planning Commission (NHFPC). In response, the government of China invested USD 2.2 billion in acceleration and streamlining of regulatory approvals for new CR devices to cope with the surge in tier-2 city expansion.

India is experiencing a robust emergence in the cardiac rehabilitation market with increased CVD mortalities and government initiatives. Particularly, the trend of improving public access to better heart-related healthcare through infrastructural development and digitalization is reflecting the country's potential as a progressive landscape in this sector. For instance, the commencement of the Ayushman Bharat Initiative funded over 202 specialized CR centers nationwide, demonstrating the steady cash inflow in this category. Furthermore, the proactive participation and spending from governing bodies in this country is bridging the access gap in this sector.

Country-wise Government Investments & Policies

Europe Market Insights

Europe is estimated to retain its position as the second-largest shareholder in the global cardiac rehabilitation market during the forecasted timeline. The region's stability in progress is attributed to the aging demography and well-established healthcare infrastructure. Particularly, the implementation of unified cardiovascular disease prevention strategies enhances patient access to advanced rehabilitation care, fueling business flow in this category. The Europe landscape has further accelerated innovation through its Health Data Space initiative, drafting an outlay of €2.6 billion. Moreover, the concentrated focus on availing high-quality medical facilities is creating greater opportunities for both domestic and foreign pioneers.

The UK is augmenting a profitable atmosphere for the cardiac rehabilitation market with a sustainable demand and the presence of global MedTech leaders. This is testified by the number of CR users registered by the National Health Service (NHS), totaling 1.3 million every year till 2024. Thus, to improve patient access in this category, the NHS allocated 8.1% of the nation's healthcare budget in 2023, which was 6.6% in 2020. The country prioritizes both traditional and digital rehabilitation solutions, demonstrating a lucrative landscape with diverse business opportunities.

Germany is progressing in the cardiac rehabilitation market with the potential to dominate the regional landscape. As the country witnessed a 12.3% rise in CR demand in 2024 from 2021, it concentrated its focus on increasing the scalability of the existing pipeline in this sector, securing a €4.2 billion revenue. In addition, the nation's governing bodies mandated a post-PCI rehabilitation policy, which further enabled access to CR products and services for a remarkable 92.4% of eligible patients nationwide in 2023. Moreover, the compulsory treatment protocols, coupled with a robust reimbursement system, Germany is reflecting a prosperous future in this merchandise.